(Q37268421)

English

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study

scientific article published on 28 June 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Vasilios Berdoukas

1

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Giorgos Chouliaras

2

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Panagiotis Moraitis

3

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Kirykos Zannikos

4

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Eleni Berdoussi

5

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Vassilios Ladis

6

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

publication date

28 June 2009

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Journal of Cardiovascular Magnetic Resonance

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

20

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

28 June 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1532-429x-11-20

0 references

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Longitudinal analysis of heart and liver iron in thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Measurement and mapping of liver iron concentrations using magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

6 September 2017

Longitudinal study of survival and causes of death in patients with thalassemia major in Greece

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

14 September 2017

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

26 June 2018

Hepatic iron concentration and total body iron stores in thalassemia major.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

26 June 2018

Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Liver iron concentration and fibrosis in a cohort of transfusion-dependent patients on long-term desferrioxamine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Reversal of heart failure in thalassemia major by combined chelation therapy: a case report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Cardiac status in well-treated patients with thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Hepatocellular carcinoma in the thalassaemia syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Impact of thalassemia major on patients and their families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2713224

3 September 2018

Combined therapy with deferiprone and desferrioxamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19558722

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1532-429X-11-20

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37268421&oldid=2091468673"